Variant report

Variant	nsv877646
Chromosome Location	chr3:150582992-150641304
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:150583165-150583403	K562	blood:	n/a	n/a
2	ARID3A	chr3:150583068-150583385	HepG2	liver:	n/a	n/a
3	ATF1	chr3:150583168-150583428	K562	blood:	n/a	n/a
4	ATF2	chr3:150583070-150583464	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr3:150641002-150641130	K562	blood:	n/a	n/a
6	BATF	chr3:150630257-150630676	GM12878	blood:	n/a	chr3:150630501-150630511 chr3:150630500-150630511
7	BATF	chr3:150630310-150630553	GM12878	blood:	n/a	chr3:150630501-150630511 chr3:150630500-150630511
8	BATF	chr3:150593330-150593578	GM12878	blood:	n/a	n/a
9	BCLAF1	chr3:150583014-150583538	GM12878	blood:	n/a	n/a
10	BHLHE40	chr3:150583003-150583422	K562	blood:	n/a	n/a
11	BHLHE40	chr3:150639017-150639325	HepG2	liver:	n/a	n/a
12	CCNT2	chr3:150583003-150583405	K562	blood:	n/a	n/a
13	CEBPB	chr3:150599661-150599697	HepG2	liver:	n/a	n/a
14	CEBPB	chr3:150621673-150621946	HepG2	liver:	n/a	chr3:150621799-150621812 chr3:150621801-150621810 chr3:150621800-150621811
15	CEBPB	chr3:150595189-150595381	Hela-S3	cervix:	n/a	chr3:150595300-150595313
16	CEBPB	chr3:150604866-150605081	A549	lung:	n/a	n/a
17	CEBPB	chr3:150621795-150621811	Hela-S3	cervix:	n/a	chr3:150621801-150621810 chr3:150621800-150621811
18	CEBPB	chr3:150604828-150605080	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr3:150593799-150594106	IMR90	lung:	n/a	chr3:150593945-150593956 chr3:150593946-150593955
20	CEBPB	chr3:150604797-150605067	IMR90	lung:	n/a	n/a
21	CEBPB	chr3:150588988-150589367	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr3:150608149-150608460	Hela-S3	cervix:	n/a	chr3:150608273-150608284 chr3:150608271-150608284 chr3:150608271-150608282
23	CEBPB	chr3:150593848-150594063	HepG2	liver:	n/a	chr3:150593945-150593956 chr3:150593946-150593955
24	CEBPB	chr3:150621761-150621905	K562	blood:	n/a	chr3:150621799-150621812 chr3:150621801-150621810 chr3:150621800-150621811
25	CEBPB	chr3:150583144-150583367	K562	blood:	n/a	n/a
26	CEBPB	chr3:150630052-150630450	A549	lung:	n/a	chr3:150630344-150630355 chr3:150630344-150630357 chr3:150630346-150630355 chr3:150630346-150630355 chr3:150630344-150630357 chr3:150630346-150630355 chr3:150630346-150630355
27	CEBPB	chr3:150621740-150621837	A549	lung:	n/a	chr3:150621799-150621812 chr3:150621801-150621810 chr3:150621800-150621811
28	CEBPB	chr3:150608117-150608477	IMR90	lung:	n/a	chr3:150608273-150608284 chr3:150608271-150608284 chr3:150608271-150608282
29	CEBPB	chr3:150608170-150608408	HepG2	liver:	n/a	chr3:150608273-150608284 chr3:150608271-150608284 chr3:150608271-150608282
30	CEBPB	chr3:150589031-150589292	IMR90	lung:	n/a	n/a
31	CEBPB	chr3:150583142-150583420	Hela-S3	cervix:	n/a	n/a
32	CEBPB	chr3:150589034-150589323	A549	lung:	n/a	n/a
33	CTCF	chr3:150583200-150583350	NHEK	skin:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
34	CTCF	chr3:150583053-150583504	A549	lung:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
35	CTCF	chr3:150583160-150583310	NHDF-neo	bronchial:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
36	CTCF	chr3:150583207-150583402	GM19238	blood:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
37	CTCF	chr3:150583200-150583350	HCPEpiC	choroid plexus:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
38	CTCF	chr3:150583125-150583416	H1-hESC	embryonic stem cell:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
39	CTCF	chr3:150583088-150583399	Medullo	brain:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
40	CTCF	chr3:150583220-150583370	WERI-Rb-1	eye:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
41	CTCF	chr3:150583340-150583490	HFF	foreskin:	n/a	n/a
42	CTCF	chr3:150583096-150583470	A549	lung:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
43	CTCF	chr3:150582906-150583578	MCF-7	breast:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
44	CTCF	chr3:150583300-150583450	WI-38	lung:	n/a	n/a
45	CTCF	chr3:150583179-150583378	HepG2	liver:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
46	CTCF	chr3:150583160-150583310	GM12872	blood:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
47	CTCF	chr3:150583121-150583421	K562	blood:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
48	CTCF	chr3:150583086-150583388	T-47D	breast:	n/a	chr3:150583254-150583267 chr3:150583252-150583270 chr3:150583253-150583269 chr3:150583247-150583268
49	CTCF	chr3:150583100-150583250	NHLF	lung:	n/a	n/a
50	CTCF	chr3:150636456-150636513	H1-hESC	embryonic stem cell:	n/a	chr3:150636491-150636509 chr3:150636486-150636507 chr3:150636493-150636506 chr3:150636492-150636508

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:150621326-150621376	Hela-S3	cervix:	n/a
2	chr3:150621326-150621376	PrEC	prostate:	n/a
3	chr3:150638295-150638345	AoSMC	blood vessel:	n/a
4	chr3:150638295-150638345	HCT-116	colon:	n/a
5	chr3:150621326-150621376	AG09309	skin:	n/a
6	chr3:150621326-150621376	NH-A	brain:	n/a
7	chr3:150621326-150621376	RPTEC	kidney:	n/a
8	chr3:150638295-150638345	BJ	skin:	n/a
9	chr3:150638295-150638345	HEK293	kidney:	embryo
10	chr3:150621326-150621376	HepG2	liver:	n/a
11	chr3:150638295-150638345	PANC-1	pancreas:	n/a
12	chr3:150638295-150638345	NH-A	brain:	n/a
13	chr3:150621326-150621376	HCT-116	colon:	n/a
14	chr3:150621326-150621376	GM06990	blood:	n/a
15	chr3:150638295-150638345	MCF10A-Er-Src	breast:	n/a
16	chr3:150621326-150621376	BJ	skin:	n/a
17	chr3:150638295-150638345	SAEC	small airway:	n/a
18	chr3:150638295-150638345	A549	lung:	n/a
19	chr3:150621326-150621376	AoSMC	blood vessel:	n/a
20	chr3:150621326-150621376	SK-N-SH_RA	brain:	n/a
21	chr3:150638295-150638345	NHBE	bronchial:	n/a
22	chr3:150621326-150621376	NB4	blood:	n/a
23	chr3:150638295-150638345	IMR90	lung:	fetal
24	chr3:150638295-150638345	SK-N-SH	brain:	n/a
25	chr3:150621326-150621376	Hepatocyte	liver:	n/a
26	chr3:150621326-150621376	HMEC	breast:	n/a
27	chr3:150621326-150621376	MCF-7	breast:	n/a
28	chr3:150638295-150638345	HUVEC	blood vessel:	n/a
29	chr3:150621326-150621376	H1-hESC	embryonic stem cell:	embryo
30	chr3:150638295-150638345	HNPCEpiC	eye:	n/a
31	chr3:150621326-150621376	HL-60	blood:	n/a
32	chr3:150638295-150638345	HAEpiC	amniotic membrane:	n/a
33	chr3:150621326-150621376	K562	blood:	n/a
34	chr3:150621326-150621376	ECC-1	luminal epithelium:	n/a
35	chr3:150638295-150638345	GM12891	blood:	n/a
36	chr3:150621326-150621376	SK-N-MC	brain:	n/a
37	chr3:150621326-150621376	HCM	heart:	n/a
38	chr3:150638295-150638345	GM19239	blood:	n/a
39	chr3:150638295-150638345	HEEpiC	esophagus:	n/a
40	chr3:150621326-150621376	HPAEpiC	pulmonary alveolar:	n/a
41	chr3:150621326-150621376	Jurkat	blood:	n/a
42	chr3:150621326-150621376	NHBE	bronchial:	n/a
43	chr3:150621326-150621376	HRPEpiC	eye:	n/a
44	chr3:150621326-150621376	GM12892	blood:	n/a
45	chr3:150638295-150638345	SK-N-SH_RA	brain:	n/a
46	chr3:150638295-150638345	HCF	heart:	n/a
47	chr3:150621326-150621376	ovcar-3	ovarian:	n/a
48	chr3:150638295-150638345	AG09309	skin:	n/a
49	chr3:150638295-150638345	GM12892	blood:	n/a
50	chr3:150638295-150638345	HCPEpiC	choroid plexus:	n/a

No.	Distal block	Cell Line	Cell type
1	chr3:150623156..150625349-chr3:150626620..150628452,2	MCF-7	breast:
2	chr3:150614748..150616518-chr3:150617280..150620214,2	K562	blood:
3	chr3:150586336..150588790-chr3:150802703..150804787,2	MCF-7	breast:
4	chr3:150583250..150586861-chr3:150588416..150592183,4	K562	blood:
5	chr3:150641035..150643742-chr3:150654754..150657787,3	MCF-7	breast:
6	chr3:150626529..150628111-chr3:150637179..150639956,2	MCF-7	breast:
7	chr3:150615182..150618213-chr3:150621326..150624872,3	K562	blood:
8	chr3:150558309..150558816-chr3:150582852..150583509,2	MCF-7	breast:
9	chr3:150623156..150625349-chr3:150626620..150628452,2	MCF-7	breast:
10	chr3:150584605..150586151-chr3:150588439..150591426,2	K562	blood:
11	chr3:150622090..150624886-chr3:150628966..150632795,3	MCF-7	breast:
12	chr3:150478330..150480784-chr3:150625078..150627756,3	MCF-7	breast:
13	chr3:150548154..150548723-chr3:150582876..150583541,2	MCF-7	breast:
14	chr3:150583250..150586861-chr3:150588416..150592183,4	K562	blood:
15	chr3:150615265..150617813-chr3:150619650..150621718,2	MCF-7	breast:
16	chr3:150614748..150616518-chr3:150617280..150620214,2	K562	blood:
17	chr3:150504367..150507442-chr3:150579602..150583163,3	MCF-7	breast:
18	chr3:150505248..150506241-chr3:150582658..150583739,6	K562	blood:
19	chr3:150478755..150482911-chr3:150581723..150585653,5	MCF-7	breast:
20	chr3:150622090..150624886-chr3:150628966..150632795,3	MCF-7	breast:
21	chr3:150482364..150486179-chr3:150581053..150584766,4	MCF-7	breast:
22	chr3:150320455..150323274-chr3:150591943..150594303,2	K562	blood:
23	chr3:150439035..150439884-chr3:150583116..150584203,3	MCF-7	breast:
24	chr3:150618519..150622479-chr3:150624058..150626415,3	K562	blood:
25	chr3:150627920..150630352-chr3:150630947..150632626,2	K562	blood:
26	chr3:150595796..150597969-chr3:150600238..150602969,2	K562	blood:
27	chr3:150438822..150439787-chr3:150582598..150583745,7	K562	blood:
28	chr3:150627920..150630352-chr3:150630947..150632626,2	K562	blood:
29	chr3:150595796..150597969-chr3:150600238..150602969,2	K562	blood:
30	chr3:150479297..150481963-chr3:150584720..150587723,3	MCF-7	breast:
31	chr3:150617220..150619793-chr3:150619915..150623246,3	MCF-7	breast:
32	chr3:150505282..150506183-chr3:150582828..150583680,5	MCF-7	breast:
33	chr3:150586127..150590392-chr3:150594321..150596821,3	MCF-7	breast:
34	chr3:150439194..150440771-chr3:150583171..150584932,2	MCF-7	breast:
35	chr3:150586127..150590392-chr3:150594321..150596821,3	MCF-7	breast:
36	chr3:150615182..150618213-chr3:150621326..150624872,3	K562	blood:
37	chr3:150635212..150636837-chr3:150639555..150642530,2	K562	blood:
38	chr3:150624732..150627491-chr3:150803111..150805628,2	MCF-7	breast:
39	chr3:150442212..150446114-chr3:150585527..150588995,3	MCF-7	breast:
40	chr3:150579861..150581386-chr3:150589739..150591900,2	K562	blood:
41	chr3:150626529..150628111-chr3:150637179..150639956,2	MCF-7	breast:
42	chr3:150584605..150586151-chr3:150588439..150591426,2	K562	blood:
43	chr3:150438851..150440084-chr3:150582767..150583714,6	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FAM188B2-1	chr3:150618941-150619243	XLOC_003285
2	lnc-MED12L-2	chr3:150608647-150608657	XLOC_002874
3	lnc-MED12L-2	chr3:150609833-150610167	XLOC_002874
4	lnc-MED12L-2	chr3:150608423-150608657	ENSG00000243273.1
5	lnc-FAM188B2-1	chr3:150621036-150621181	XLOC_003285

Variant related genes	Relation type
ENSG00000243273	TF binding region
ENSG00000222079	TF binding region
FAM188B2	TF binding region
ENSG00000244382	TF binding region
ENSG00000243273	CpG island
ENSG00000222079	CpG island
FAM188B2	CpG island
ENSG00000244382	CpG island
ENSG00000244382	chromatin interactions
ENSG00000222079	chromatin interactions
ENSG00000181788	chromatin interactions
ENSG00000244265	chromatin interactions
ENSG00000144893	chromatin interactions
ENSG00000120742	chromatin interactions
ENSG00000198843	chromatin interactions
BCL2	miRNA target sites

Extended variants
information (count: 2329 )
Associated
traits (count: 50 )

Variant overlapped rSNPs/rCNVs (count:2329 , 50 per page) page: 1 2 3 4 5 6 7 ... 47

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2037409	chr3:150582992-150582993	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs540330862	chr3:150583069-150583070	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs536326984	chr3:150583075-150583076	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs567018307	chr3:150583100-150583101	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs553184616	chr3:150583107-150583108	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs552131482	chr3:150583118-150583119	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs142100458	chr3:150583169-150583170	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs145845864	chr3:150583183-150583184	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs371432945	chr3:150583280-150583281	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs376985061	chr3:150583281-150583282	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs200751254	chr3:150583312-150583313	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs373376747	chr3:150583313-150583314	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs59433651	chr3:150583314-150583315	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs73871614	chr3:150583316-150583317	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs544232422	chr3:150583318-150583319	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs564995357	chr3:150583345-150583346	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs554263035	chr3:150583348-150583349	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs200412875	chr3:150583354-150583355	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs184520101	chr3:150583423-150583424	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs370497150	chr3:150583517-150583518	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs560257901	chr3:150583565-150583566	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs73152585	chr3:150583591-150583592	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs545974754	chr3:150583675-150583676	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs562811602	chr3:150583733-150583734	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs544775165	chr3:150583738-150583739	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs531499192	chr3:150583752-150583753	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs190560298	chr3:150583757-150583758	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs202140484	chr3:150583764-150583765	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs114553102	chr3:150583770-150583771	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs577190300	chr3:150583771-150583772	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs76645329	chr3:150583787-150583788	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs530069838	chr3:150583788-150583789	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs530747834	chr3:150583822-150583823	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs546711162	chr3:150583856-150583857	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs566579299	chr3:150583925-150583926	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs180846183	chr3:150583934-150583935	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs552341135	chr3:150583944-150583945	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs186087960	chr3:150583957-150583958	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs138693116	chr3:150583968-150583969	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs554585432	chr3:150584052-150584053	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs574367319	chr3:150584058-150584059	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs199519241	chr3:150584075-150584076	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs368620056	chr3:150584079-150584080	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs201771134	chr3:150584081-150584082	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs533744451	chr3:150584101-150584102	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs553909414	chr3:150584127-150584128	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs191336184	chr3:150584151-150584152	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs576972622	chr3:150584197-150584198	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs546062715	chr3:150584287-150584288	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs562539653	chr3:150584298-150584299	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:50)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Hepatocellular carcinoma	16750200	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Breast cancer	16608533	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	16773561	CNVD
Non-small cell lung cancer	19010865	CNVD
abnormal development	18461090	CNVD
Myelofibrosis	22110671	CNVD
Uveal melanoma	20484589	CNVD

Chromatin state (count:308 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:150579600-150583000	Weak transcription	Primary neutrophils fromperipheralblood	blood
2	chr3:150580000-150584400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr3:150580600-150583000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr3:150582600-150583400	Enhancers	Placenta	Placenta
5	chr3:150582600-150583600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr3:150583000-150583200	Enhancers	Primary hematopoietic stem cells	blood
7	chr3:150583000-150583200	Flanking Active TSS	Fetal Heart	heart
8	chr3:150583000-150583200	Enhancers	HMEC	breast
9	chr3:150583000-150583400	Enhancers	Primary T helper cells PMA-I stimulated	--
10	chr3:150583000-150583400	Enhancers	Liver	Liver
11	chr3:150583000-150583400	Flanking Active TSS	Stomach Mucosa	stomach
12	chr3:150583000-150583400	Enhancers	Osteobl	bone
13	chr3:150583000-150583600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr3:150583000-150583600	Enhancers	Primary neutrophils fromperipheralblood	blood
15	chr3:150583000-150583600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
16	chr3:150583000-150583600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
17	chr3:150583000-150583600	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
18	chr3:150583200-150583600	Enhancers	Hela-S3	cervix
19	chr3:150583200-150583800	Enhancers	Fetal Heart	heart
20	chr3:150583200-150584400	Weak transcription	Primary hematopoietic stem cells	blood
21	chr3:150583400-150583600	Enhancers	Stomach Mucosa	stomach
22	chr3:150583400-150583800	Weak transcription	Placenta	Placenta
23	chr3:150583400-150588200	Weak transcription	Osteobl	bone
24	chr3:150583600-150585000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr3:150583600-150586000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr3:150583600-150586200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr3:150583600-150588400	Weak transcription	Primary neutrophils fromperipheralblood	blood
28	chr3:150583800-150584200	Weak transcription	Fetal Heart	heart
29	chr3:150583800-150591200	Enhancers	Placenta	Placenta
30	chr3:150584200-150584800	Enhancers	Fetal Heart	heart
31	chr3:150584400-150584600	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr3:150584400-150584800	Enhancers	Fetal Muscle Leg	muscle
33	chr3:150584400-150585800	Enhancers	Primary hematopoietic stem cells	blood
34	chr3:150584600-150585800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
35	chr3:150584600-150586000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr3:150584800-150587400	Weak transcription	Fetal Heart	heart
37	chr3:150584800-150587800	Weak transcription	Fetal Muscle Leg	muscle
38	chr3:150585000-150585200	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
39	chr3:150585000-150586000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr3:150585800-150586400	Enhancers	Left Ventricle	heart
41	chr3:150585800-150586600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr3:150586000-150586400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
43	chr3:150586000-150586400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr3:150586000-150586400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
45	chr3:150586200-150586400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
46	chr3:150586200-150586600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr3:150586200-150586600	Enhancers	HSMMtube	muscle
48	chr3:150586400-150588200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
49	chr3:150586400-150588400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
50	chr3:150586400-150588400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links